Bajaj Healthcare Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter

The Bajaj Healthcare Q2 results FY27 announcement is the next scheduled earnings event for Bajaj Healthcare Ltd., a pharmaceutical company making active pharmaceutical ingredients, intermediates and finished formulations for domestic and export customers. The stock traded at Rs 332.25 on the NSE on 9 September 2026, down 1.32% from the previous close of Rs 336.70, about 35.6% below its 52-week high of Rs 515.90 and 22.0% above its 52-week low of Rs 272.35.

What makes the Bajaj Healthcare Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 148.00 crore of revenue and a profit of Rs 11.00 crore, while the most recent quarter on record, Q1 FY27, produced Rs 166.00 crore and a profit of Rs 14.00 crore. Everything below is built from those reported figures rather than from any forecast.

Click Here – Get Free Investment Predictions

When Is the Bajaj Healthcare Q2 Results FY27 Date?

The Bajaj Healthcare Q2 results date for FY27 is not confirmed. As of 9 September 2026, Bajaj Healthcare Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.

What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Bajaj Healthcare Q2 results date becomes public through that filing rather than through any advance announcement.

The Bajaj Healthcare Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Bajaj Healthcare.

Bajaj Healthcare Q2 Results Expectations: What the Market Is Actually Tracking

No verified analyst estimate for the Bajaj Healthcare Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Bajaj Healthcare. The Bajaj Healthcare Q2 results watchlist below is built from what the company has actually reported and disclosed.

The first is revenue, which has held in a narrow Rs 148 crore to Rs 166 crore band across all five quarters. September 2025 was the lowest of them at Rs 148 crore, so the base for the year-on-year comparison is a soft one.

The second is the operating margin, which was 18% in September 2025 and 17% in Q1 FY27, having ranged between 15% and 19% over the five quarters. There is no trend in it either way.

The third is other income. It ran at about Rs 1 crore a quarter except in March 2026, when it was negative Rs 34 crore and turned a Rs 23 crore operating profit into a Rs 23 crore net loss. Whether the September quarter carries any further charge of that kind is the largest single unknown in the print.

Check Bajaj Healthcare Ltd. Live Fundamentals on the Univest Screener

Bajaj Healthcare Q2 Results Preview: The Q1 FY27 Actuals It Builds On

Bajaj Healthcare Ltd. reported revenue of Rs 166.00 crore in Q1 FY27, up 11.41% from Rs 149.00 crore in Q1 FY26, and a profit of Rs 14.00 crore at the net level, up 16.67% from Rs 12.00 crore in Q1 FY26. These are reported actuals, not estimates.

Sequentially, revenue was up 8.50% over the March 2026 quarter figure of Rs 153.00 crore, and net profit was a swing from a loss of Rs 23.00 crore in Q4 FY26 to a profit of Rs 14.00 crore. Operating margin stood at 17% in Q1 FY27 against 18% in the September 2025 quarter, which is the comparison the Bajaj Healthcare Q2 results print will be read against.

Q2 FY26 Base: The Comparison Bajaj Healthcare Q2 Results FY27 Must Beat

Bajaj Healthcare Ltd. reported revenue of Rs 148.00 crore and a profit of Rs 11.00 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Bajaj Healthcare Q2 results preview.

Net profit in that base quarter was below the Rs 14.00 crore just reported for Q1 FY27, so the year-on-year comparison starts from a manageable level. Revenue of Rs 148.00 crore sits below the Rs 166.00 crore of the June 2026 quarter, which frames how much sequential movement the Bajaj Healthcare Q2 results print needs to show growth.

Bajaj Healthcare Quarterly Results Trend Over the Last Four Quarters

Quarter	Revenue (Rs Cr)	Net Profit (Rs Cr)
Q2 FY26 (Sep 2025)	148.00	11.00
Q3 FY26 (Dec 2025)	161.00	16.00
Q4 FY26 (Mar 2026)	153.00	(23.00)
Q1 FY27 (Jun 2026)	166.00	14.00

Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company's exchange filings, and they are the only basis this Bajaj Healthcare Q2 results preview uses.

Revenue across those four quarters ranged from Rs 148.00 crore to Rs 166.00 crore, and net profit from Rs 23.00 crore loss to Rs 16.00 crore. That spread is the honest context for the Bajaj Healthcare Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.

Key Factors That Could Shape Bajaj Healthcare Q2 Results FY27

The Bajaj Healthcare Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Bajaj Healthcare has already reported.

Ingredients Against Finished Formulations

Active pharmaceutical ingredients and finished dosage products carry different margins and different customer concentration. The split between them in a given quarter explains most of the movement in the operating margin.

The March 2026 Write-Off

The negative Rs 34 crore other income in March 2026 came alongside a negative 6% tax rate, so both lines below operating profit moved together. That combination is the signature of a one-off adjustment rather than trading performance, and the company's own notes to the accounts are where it is explained.

Interest on a Moderate Debt Load

Borrowings of about Rs 249 crore against reserves of Rs 516 crore give a debt to equity ratio of 0.47. On quarterly operating profit of Rs 23 crore to Rs 31 crore, the interest charge is large enough to matter to the net profit line.

Bajaj Healthcare Q2 Results FY27: Share Price and Valuation Going Into the Print

Bajaj Healthcare share price today is Rs 332.25 on the NSE, down Rs 4.45 or 1.32% from the previous close of Rs 336.70 on 9 September 2026, ahead of the Bajaj Healthcare Q2 results announcement.

Metric	Value (9 September 2026)
NSE Symbol	BAJAJHCARE
Current Market Price	Rs 332.25
52-Week High	Rs 515.90
52-Week Low	Rs 272.35
Market Capitalisation	Rs 1,118 crore
PE Ratio	19.89
PB Ratio	2.10
EPS (TTM)	Rs 16.70
Book Value per Share	Rs 158.00
Debt to Equity	0.47
Return on Equity	9.40%
50-Day Moving Average	Rs 334.33
200-Day Moving Average	Rs 344.84
RSI (14)	55.26

The stock trades below both its 50-day average of Rs 334.33 and its 200-day average of Rs 344.84, with a 14-day RSI of 55.26. None of this is a view on where the shares go once the Bajaj Healthcare Q2 results are announced, and no price target is offered here.

Download the Univest iOS App or Univest Android App to track Bajaj Healthcare Ltd. live price and quarterly earnings updates.

What Investors Should Watch When Bajaj Healthcare Q2 Results Are Announced

Four lines carry most of the information in a company of this size, and reading them in order keeps the Bajaj Healthcare Q2 results print in proportion.

1. Revenue against the Rs 148.00 crore reported in the September 2025 base quarter
2. Net profit against a profit of Rs 11.00 crore in that same quarter
3. Operating margin against 17% in Q1 FY27
4. Any exceptional item, provision or one-off gain disclosed alongside the numbers

A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Bajaj Healthcare Q2 results announcement should be read together with the notes to the results rather than the headline alone.

Conclusion on Bajaj Healthcare Q2 Results FY27

The Bajaj Healthcare Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Bajaj Healthcare Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.

On that basis the Bajaj Healthcare Q2 results FY27 print faces a base of Rs 148.00 crore in revenue and a profit of Rs 11.00 crore, with the most recent quarter having delivered Rs 166.00 crore and a profit of Rs 14.00 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Bajaj Healthcare, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.

FAQs on Bajaj Healthcare Q2 Results FY27

What is the Bajaj Healthcare Q2 results date for FY27?

Ans. The Bajaj Healthcare Q2 results date for FY27 is not confirmed. Bajaj Healthcare Ltd. had not filed a board meeting intimation with the NSE or BSE as of 9 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.

What quarter do the Bajaj Healthcare Q2 results 2026 cover?

Ans. The Bajaj Healthcare Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Bajaj Healthcare Ltd. reports revenue, operating profit and net profit for that period, and the Bajaj Healthcare Q2 results filing also carries the notes to the accounts.

What were the Bajaj Healthcare Q1 FY27 results?

Ans. Bajaj Healthcare Ltd. reported revenue of Rs 166.00 crore in Q1 FY27 and a profit of Rs 14.00 crore at the net level. Revenue was up 11.41% versus Q1 FY26 and net profit was up 16.67% from Rs 12.00 crore in Q1 FY26.

What were Bajaj Healthcare Q2 FY26 results in the September 2025 quarter?

Ans. Bajaj Healthcare Ltd. reported revenue of Rs 148.00 crore and a profit of Rs 11.00 crore in Q2 FY26. Operating margin was 18%. Those figures form the base for the Bajaj Healthcare Q2 results FY27 comparison.

What are the main Bajaj Healthcare Q2 results expectations this quarter?

Ans. No verified analyst estimate is publicly available. The Bajaj Healthcare Q2 results expectations centre on revenue against the Rs 148.00 crore base, net profit against a profit of Rs 11.00 crore, operating margin against 17% in Q1 FY27, and any exceptional item disclosed with the numbers.

What is Bajaj Healthcare share price today ahead of the Q2 earnings?

Ans. Bajaj Healthcare share price is Rs 332.25 on the NSE as of 9 September 2026, down 1.32% from Rs 336.70. The stock is about 35.6% below its 52-week high of Rs 515.90 and 22.0% above its 52-week low of Rs 272.35, at a market capitalisation of Rs 1,118 crore.

Is Bajaj Healthcare a good stock to buy before the Q2 results?

Ans. This article does not offer a buy, sell or hold recommendation on Bajaj Healthcare Ltd. The stock trades at a price-to-book ratio of 2.10 with a return on equity of 9.40%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.